FDA Proposes Suicide Warnings on Antidepressants

Christina Cole

Contributor

0 CommentsPrint ArticleSubscribe

The FDA has requested that the makers of antidepressant drugs expand their warning labels to include adults age 18-24. The labels currently have similar warnings for adolescents and children.

The maker of Prozac - Eli Lily Co and Pfizer Inc - Zoloft manufacturer and many other drug companies, said they will comply with the FDA's request.

"We believe this step will help ensure that the millions of people with depression who are young adults age 24 and under and their families can make informed treatment decisions while minimizing the fear and stigma associated with depression," Eli Lilly said in a statement.

The new labels would note that studies have not shown an increased risk in adults older than 24 and adults 65 and older taking antidepressants that have decreased risks of suicidal behavior and thoughts.

The expanded warnings will emphasize that depression and other disorders themselves are usually the most important cause of suicide.

The proposed changes came with the endorsement of FDA expert advisers. Some experts have argued that the changes are overdue while others maintain they could keep drugs from those who need them.

Last month, a comprehensive analysis of antidepressants for children and teenagers found the benefits of treatment trump the small risk of increasing suicidal thoughts and behaviors in some patients.